ADVERTISEMENT
News
Antiviral Drug Recalled
02/12/2021
The recall affects 46,479 bottles of oseltamivir phosphate for oral suspension, 6 mg/mL, 60 mL (NDC 68180-678-01), from lot A906423 (Exp. 11/21). The product was distributed throughout the United States.
Lupin Pharmaceuticals initiated the recall January 21, 2021. On February 3, 2021, the FDA designated the recall Class III. Under the recall classification, use of the affected product is not likely to cause harm.
Oseltamivir is a prescription antiviral medication used to treat symptoms caused by the flu.
—Jolynn Tumolo
Stay Informed & Sign Up Today
Pharmacy Learning Network Newsletter
